Commitment to Quality
Peptides International has a long history of providing quality products documented by detailed descriptions and analytical specifications. As a research-based company, we know first hand how important the quality of a scientist's reactants are to the success of his or her research. The company also recognizes the importance of quality throughout its operations and has engaged in an extensive effort that will harmonize its internally-developed systems with those necessary for external certification. Customer audits of our quality systems and facilities are welcome.
Facilities and Location
Technical and commercial activities are housed in a newly expanded and renovated facility in the Bluegrass Industrial Park, which is just east of metropolitan Louisville, Kentucky. With its central US location and close proximity to both United Parcel Service (UPS) and Federal Express (FedEx), products from Peptides can easily be shipped overnight to destinations around the world.
Sales and Distribution Channels
While direct sales via telephone, fax, or this website are preferred for many countries, Peptides International encourages sales in the following countries to utilize the in-country services of the following distributors:
Japan
Peptide Institute, Inc.
4-1-2 Ina Minoh-SHI
Osaka 5621 Japan
Phone (0727) 29-4121
Fax (0727) 29-4124
http://www.peptide.co.jp
Switzerland
LuBioScience GmbH
Topferstrasse 5
P.O. Box 6000
Lucerne 6
Switzerland
Phone
0041 41 417 02 80
Fax 0041 41 417 02 89
www.lubio.ch
Belgium
Netherlands
Luxembourg
Bio-Connect BV
Begonialaan 3a
6851 TE Huissen
The Netherlands
Phone
31 (0)26 326 4450
Fax 31 (0)26 326 4451
www.bio-connect.nl
People and Organization
The company is privately owned with Jacqulyn Spatola as principal shareholder and chair of the Board. Members of the Board, in addition to Ms. Spatola and Dr. Johnson, include four highly qualified individuals with extensive expertise in the medical sciences, business management, finance, and sales and marketing.
Management Personnel
Bryce V. Johnson, Ph.D. - President/CEO
Channa Basava, Ph.D. - Chief Operating Officer
DeAnna W. Long, Ph.D. - Director of Sales and Marketing
Patricia Y. Coxon, Ph.D. - Quality Assurance Manager
Jacqulyn B. Spatola - Administration/Finance
Biography of Dr. Arno F. Spatola, Founder of Peptides International
Arno F. Spatola was born in Albany, New York in 1944. He received his undergraduate degree in chemistry from Cornell University and his Master and Doctorate degrees from the University of Michigan with Prof. Daniel T. Longone. Under the direction of Dr. Victor J. Hruby at the University of Arizona, Dr. Spatola's postdoctoral research focused on peptide synthesis and structure-function studies, marking the beginning of his distinguished career in peptide science. This led to his 1973 recruitment by the University of Louisville's Chemistry Department to initiate a peptide research program in Louisville, Kentucky.
While at the University of Louisville Professor Spatola became an internationally recognized peptide chemistry researcher. During his academic tenure, his major research interests included biologically active peptides, pseudopeptides, cyclic peptides, and cyclic peptide libraries. He originated the (psi) pseudopeptide nomenclature, formally adopted by IUPAC. Notable contributions include Dr. Spatola's development of backbone-modified peptides (including CH2S, CH2SO, CH2NH, and CSNH), matrix metalloprotease (MMP) inhibitors, ammonium formate catalytic transfer hydrogenation (AFCTH), and cyclic peptide libraries. Dr. Spatola authored over 140 papers and six patents during the course of his research. In 1982 and in 1990, Dr. Spatola served as a visiting professor at the University of Padova, Italy.
In 1996, Dr. Spatola founded and served as Executive Director of the University of Louisville's Institute for Molecular Diversity and Drug Design (IMD3), a multidisciplinary research and training program focusing on drug design and discovery. Dr. Spatola was a founding member of the American Peptide Society, a member of the American Chemical Society, and served on the editorial boards of the Journal of Peptide Research and Letters in Peptide Science. He was an ad hoc reviewer for the National Institutes of Health and a co-chairman of the 1990 Gordon Research Conference on Chemistry and Biology of Peptides.
In 1983, Dr Spatola founded Peptides International as an outgrowth of his research interests. Under his guidance, it has developed into the company it is today. In the words of Sir Isaac Newton, often reiterated by Arno, "if we have seen further it is by standing on the shoulders of giants." Peptides International proudly remembers Arno F. Spatola for his contributions to peptide research and to the Company. We thank him for allowing us to stand on his shoulders and challenging all of us to go even further than we can ever hope to see.